Advances in Research on Protein Arginine Methyltransferase 2: Functions and Diseases

被引:2
作者
Min, Zhen-Qi [1 ]
Jiang, Ming-Jun [1 ]
Liu, Xi-Lian [2 ]
Yuan, Su-Peng [1 ]
Chen, Ping-An [1 ]
Wang, Chu-Hao [1 ]
Chen, Ya-Jun [2 ]
Dai, Xian-Peng [1 ]
机构
[1] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Vasc Surg, POB 421001, Hengyang, Peoples R China
[2] Univ South China, Affiliated Hosp 2, Hengyang Med Sch, Dept Endocrinol, POB 421001, Hengyang, Peoples R China
关键词
PRMT2; epigenetic regulation; transcriptional regulation; malignancies; atherosclerosis; inflammation; RNA-POLYMERASE-II; MOLECULAR CYTOGENETIC CHARACTERIZATION; C-TERMINAL DOMAIN; HISTONE H3; IN-VIVO; SELECTIVE INHIBITOR; EXPRESSION ANALYSIS; PRENATAL-DIAGNOSIS; RING CHROMOSOME-21; STRUCTURAL BASIS;
D O I
10.2174/0109298665281395231211060535
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein arginine methylation stands as a prevalent post-translational modification process, exerting vital roles in cellular signal transduction, gene expression, and cell cycle regulation. Amidst the protein arginine methyltransferase (PRMT) family, PRMT2 stands as a less explored constituent. Nonetheless, its regulatory roles in transcriptional regulation, post-transcriptional modification, methylation activity regulation, immunoregulation, and developmental regulation have garnered attention. These capabilities enable PRMT2 to exert pivotal regulatory functions in certain malignancies, metabolic disorders, inflammatory diseases, and atherosclerosis. In this review, we highlight the structure and functions of PRMT2, emphasizing its association with diseases. We also discuss PRMT2 inhibitors and explore the potential for therapeutic targeting.
引用
收藏
页码:25 / 42
页数:18
相关论文
共 152 条
[1]   Cordon-bleu is an actin nucleation factor and controls neuronal morphology [J].
Ahuja, Rashmi ;
Pinyol, Roser ;
Reichenbach, Nicole ;
Custer, Laura ;
Klingensmith, John ;
Kessels, Michael M. ;
Qualmann, Britta .
CELL, 2007, 131 (02) :337-350
[2]   Protein Arginine Methyltransferase 5 Regulates ERK1/2 Signal Transduction Amplitude and Cell Fate Through CRAF [J].
Andreu-Perez, Pedro ;
Esteve-Puig, Rosaura ;
de Torre-Minguela, Carlos ;
Lopez-Fauqued, Marta ;
Josep Bech-Serra, Joan ;
Tenbaum, Stephan ;
Garcia-Trevijano, Elena R. ;
Canals, Francesc ;
Merlino, Glenn ;
Avila, Matias A. ;
Recio, Juan A. .
SCIENCE SIGNALING, 2011, 4 (190)
[3]   The protein arginine methyltransferase PRMT9 attenuates MAVS activation through arginine methylation [J].
Bai, Xuemei ;
Sui, Chao ;
Liu, Feng ;
Chen, Tian ;
Zhang, Lei ;
Zheng, Yi ;
Liu, Bingyu ;
Gao, Chengjiang .
NATURE COMMUNICATIONS, 2022, 13 (01)
[4]   HOXA9 Methylation by PRMT5 Is Essential for Endothelial Cell Expression of Leukocyte Adhesion Molecules [J].
Bandyopadhyay, Smarajit ;
Harris, Daniel P. ;
Adams, Gregory N. ;
Lause, Gregory E. ;
McHugh, Anne ;
Tillmaand, Emily G. ;
Money, Angela ;
Willard, Belinda ;
Fox, Paul L. ;
DiCorleto, Paul E. .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (07) :1202-1213
[5]   Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains [J].
Bedford, MT ;
Frankel, A ;
Yaffe, MB ;
Clarke, S ;
Leder, P ;
Richard, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) :16030-16036
[6]   Altered L-Arginine Metabolic Pathways in Gastric Cancer: Potential Therapeutic Targets and Biomarkers [J].
Bednarz-Misa, Iwona ;
Fleszar, Mariusz G. ;
Fortuna, Paulina ;
Lewandowski, Lukasz ;
Mierzchala-Pasierb, Magdalena ;
Diakowska, Dorota ;
Krzystek-Korpacka, Malgorzata .
BIOMOLECULES, 2021, 11 (08)
[7]   Arginine Methylation: The Coming of Age [J].
Blanc, Romeo S. ;
Richard, Stephane .
MOLECULAR CELL, 2017, 65 (01) :8-24
[8]   β-Catenin Primes Organizer Gene Expression by Recruiting a Histone H3 Arginine 8 Methyltransferase, Prmt2 [J].
Blythe, Shelby A. ;
Cha, Sang-Wook ;
Tadjuidje, Emmanuel ;
Heasman, Janet ;
Klein, Peter S. .
DEVELOPMENTAL CELL, 2010, 19 (02) :220-231
[9]   The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity [J].
Boisvert, FM ;
Rhie, A ;
Richard, S ;
Doherty, AJ .
CELL CYCLE, 2005, 4 (12) :1834-1841
[10]   LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity [J].
Bonday, Zahid Q. ;
Cortez, Guillermo S. ;
Grogan, Michael J. ;
Antonysamy, Stephen ;
Weichert, Ken ;
Bocchinfuso, Wayne P. ;
Li, Fengling ;
Kennedy, Steven ;
Li, Binghui ;
Mader, Mary M. ;
Arrowsmith, Cheryl H. ;
Brown, Peter J. ;
Eram, Mohammad S. ;
Szewczyk, Magdalena M. ;
Barsyte-Lovejoy, Dalia ;
Vedadi, Masoud ;
Guccione, Ernesto ;
Campbell, Robert M. .
ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (07) :612-617